Lysogene is a France-based biopharmaceutical company that researches and develops gene therapies for the treatment of central nervous system diseases.
Business Model:
Revenue: $16.4M
Employees: 11-50
Address: 18-20 rue Jacques Dulud
City: Neuilly-sur-Seine
State: île-de-france
Zip: 92200
Country: FR
Lysogene is a France-based biopharmaceutical company that researches and develops gene therapies for the treatment of central nervous system diseases.
Contact Phone:
Contact Email:
Listed Exchange:
PA
IPO Date:
3/9/2017
Ticker Symbol:
LYS
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2021 | Post-IPO Debt | 1 | $3.4M |
European Investment Bank European Investment Bank |
11/2021 | Post-IPO Debt | 1 | $4.9M |
Bpifrance Bpifrance |
11/2021 | Post-IPO Debt | $4.8M |
Bpifrance |
12/2021 | Post-IPO Debt | $17M |
European Investment Bank |
2/2021 | Post-IPO Debt | $6M | 3/2020 | Post-IPO Equity | $8.7M | 2/2017 | IPO | $24.3M | 5/2014 | Series A | 2 | $22M |
Novo Holdings Sofinnova Investments Sofinnova Investments Novo Holdings Sofinnova Investments Sofinnova Investments |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|